Secondary Logo

Journal Logo

September 2022 - Volume 117 - Issue 9

  • Jasmohan Bajaj, MD, MS, FACG and Millie Long, MD, MPH, FACG
  • 0002-9270
  • 1572-0241
  • 12
  • 12.045

Efficacy and Safety of Infliximab Retreatment in Crohn's Disease: A Multicentre, Prospective, Observational Cohort (REGAIN) Study from the GETAID

Boschetti, Gilles; Nachury, Maria; Laharie, David; More

The American Journal of Gastroenterology. 117(9):1482-1490, September 2022.

Interactive Inflammatory Bowel Disease Biologics Decision Aid Does Not Improve Patient Outcomes Over Static Education: Results From a Randomized Trial

Almario, Christopher V.; van Deen, Welmoed K.; Chen, Michelle; More

The American Journal of Gastroenterology. 117(9):1508-1518, September 2022.

Comparing Predicted Probability of Hepatocellular Carcinoma in Patients With Cirrhosis With the General Population: An Opportunity to Improve Risk Communication?

Innes, Hamish; Hamill, Victoria; McDonald, Scott A.; More

The American Journal of Gastroenterology. 117(9):1454-1461, September 2022.